Lichen China [LICN] vs Team [TISI] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lichen China Ltd. wins in 7 metrics, Team Inc. wins in 9 metrics, with 0 ties. Team Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lichen China Ltd. | Team Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.06 | N/A | N/A |
| Price-to-Book Ratio | 0.08 | -3.12 | Lichen China Ltd. |
| Debt-to-Equity Ratio | 0.56 | 1,272.61 | Lichen China Ltd. |
| PEG Ratio | N/A | -29.78 | N/A |
| EV/EBITDA | 1.66 | 9.55 | Lichen China Ltd. |
| Profit Margin (TTM) | -43.20% | -5.49% | Team Inc. |
| Operating Margin (TTM) | -36.80% | 2.97% | Team Inc. |
| EBITDA Margin (TTM) | N/A | 2.97% | N/A |
| Return on Equity | -23.98% | -336.96% | Lichen China Ltd. |
| Return on Assets (TTM) | -10.28% | 1.76% | Team Inc. |
| Free Cash Flow (TTM) | $-11.51M | $-20.64M | Lichen China Ltd. |
| 1-Year Return | -68.90% | -13.65% | Team Inc. |
| Price-to-Sales Ratio (TTM) | 2.78 | 0.09 | Team Inc. |
| Enterprise Value | $-17.34M | $462.11M | Team Inc. |
| EV/Revenue Ratio | -0.46 | 0.52 | Team Inc. |
| Gross Profit Margin (TTM) | N/A | 25.94% | N/A |
| Revenue per Share (TTM) | $162 | $199 | Team Inc. |
| Earnings per Share (Diluted) | $-71.76 | $-11.70 | Team Inc. |
| Beta (Stock Volatility) | -0.47 | 1.02 | Lichen China Ltd. |
| Short % of Float | 0.23% | 0.71% | Lichen China Ltd. |
Lichen China Ltd. vs Team Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lichen China Ltd. | 5.92% | 36.44% | -62.30% | -48.89% | -46.15% | -44.67% |
| Team Inc. | 10.39% | 5.46% | -1.68% | 19.97% | 12.14% | 19.47% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lichen China Ltd. | -68.90% | -19.05% | -62.68% | -62.68% | -62.68% | -62.68% |
| Team Inc. | -13.65% | 138.26% | -81.68% | -94.66% | -92.63% | -89.90% |
Performance & Financial Health Analysis: Lichen China Ltd. vs Team Inc.
| Metric | LICN | TISI |
|---|---|---|
| Market Information | ||
| Market Cap | $98.78M | $76.71M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 42,610 | 4,689 |
| 90 Day Avg. Volume | 57,957 | 7,917 |
| Last Close | $1.61 | $17.00 |
| 52 Week Range | $0.75 - $9.49 | $12.34 - $21.33 |
| % from 52W High | -83.04% | -20.30% |
| All-Time High | $18.00 (Feb 17, 2025) | $480.90 (Jan 13, 2014) |
| % from All-Time High | -91.06% | -96.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.21% | 0.05% |
| Quarterly Earnings Growth | N/A | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | -0.43% | -0.05% |
| Operating Margin (TTM) | -0.37% | 0.03% |
| Return on Equity (TTM) | -0.24% | -3.37% |
| Debt to Equity (MRQ) | 0.56 | 1,272.61 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $84.34 | $-5.40 |
| Cash per Share (MRQ) | $29.63 | $3.97 |
| Operating Cash Flow (TTM) | $-11,113,000 | $-11,348,000 |
| Levered Free Cash Flow (TTM) | $540,200 | $-17,296,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Lichen China Ltd. vs Team Inc.
| Metric | LICN (Apr 24, 2026) | TISI (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.06 | N/A |
| Forward P/E | N/A | -29.78 |
| PEG Ratio | N/A | -29.78 |
| Price to Sales (TTM) | 2.78 | 0.09 |
| Price to Book (MRQ) | 0.08 | -3.12 |
| Market Capitalization | ||
| Market Capitalization | $98.78M | $76.71M |
| Enterprise Value | $-17,340,320 | $462.11M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -0.46 | 0.52 |
| Enterprise to EBITDA | 1.66 | 9.55 |
| Risk & Other Metrics | ||
| Beta | -0.47 | 1.02 |
| Book Value per Share (MRQ) | $84.34 | $-5.40 |
Financial Statements Comparison: Lichen China Ltd. vs Team Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | LICN (2024) | TISI (2025) |
|---|---|---|
| Revenue/Sales | 41.48M | 896.48M |
| Cost of Goods Sold | 15.80M | 664.78M |
| COGS % of Revenue | 38.1% | 74.2% |
| Gross Profit | 25.67M | 231.71M |
| Gross Margin | 61.9% | 25.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -4.55M | 14.07M |
| Operating Margin | -11.0% | 1.6% |
| EBITDA | -1.68M | 45.26M |
| EBITDA Margin | -4.0% | 5.0% |
| Pre-Tax Income | -4.17M | -46.63M |
| Pre-Tax Income % of Revenue | -10.1% | -5.2% |
| Income Tax | 1.95M | 2.58M |
| Income Tax % of Revenue | 4.7% | 0.3% |
| Net Income (Profit) | -6.12M | -49.21M |
| Profit Margin | -14.8% | -5.5% |
Balance Sheet & Liquidity Metrics
| Metric | LICN (2024) | TISI (2025) |
|---|---|---|
| Cash & Equivalents | 26.71M | 18.15M |
| Total Current Assets | 34.01M | 266.41M |
| Total Current Assets % of Revenue | 82.0% | 29.7% |
| Total Current Liabilities | 4.27M | 120.06M |
| Total Current Liabilities % of Revenue | 10.3% | 13.4% |
| Long-Term Debt | 5,000 | 329.25M |
| Long-Term Debt % of Revenue | 0.0% | 36.7% |
| Total Shareholders Equity | 75.57M | -24.48M |
| Retained Earnings | 42.08M | -464.88M |
| Retained Earnings % of Revenue | 101.5% | -51.9% |
| Property, Plant & Equipment | 61,000 | 49.85M |
Cash Flow Statement Comparison
| Metric | LICN (2024) | TISI (2025) |
|---|---|---|
| Operating Cash Flow | 493,000 | -10.41M |
| Operating Cash Flow % of Revenue | 1.2% | -1.2% |
| Capital Expenditures | -36,000 | N/A |
| Free Cash Flow | -11.51M | -20.64M |
| FCF Margin | -27.7% | -2.3% |
| Debt Repayment | 0 | -413.27M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LICN | TISI |
|---|---|---|
| Shares Short | 37,368 | 20,328 |
| Short Ratio | 0.86 | 2.68 |
| Short % of Float | 0.23% | 0.71% |
| Shares Outstanding | 761,825 | 4.53M |
| Float Shares | 756,690 | 2.64M |
| % Held by Insiders | 0.00% | 5.72% |
| % Held by Institutions | 0.00% | 60.57% |
| % Held by Public | 100.00% | 33.71% |
Dividend Analysis & Yield Comparison: Lichen China Ltd. vs Team Inc.
| Metric | LICN | TISI |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |